Amphastar Pharmaceuticals (AMPH) Times Interest Earned (2013 - 2026)

Amphastar Pharmaceuticals' Times Interest Earned history runs 14 years deep, the most recent figure standing at $1.87 for Q1 2026.

• On a quarterly basis, Times Interest Earned fell 62.01% year-over-year to $1.87 in Q1 2026; TTM through Mar 2026 was $4.78, a 53.37% decrease from a year earlier, with the FY2025 full-year figure at $0.34, down 84.04% from the prior year.
• Times Interest Earned eased to $1.87 in Q1 2026 per AMPH's latest filing, from $5.37 in the prior quarter.
• Across five years, Times Interest Earned topped out at $36.02 in Q1 2022 and bottomed at -$418.45 in Q4 2023.
• The 5-year median for Times Interest Earned is $1.87 (2026), against an average of -$17.43.
• Across the five-year window, Times Interest Earned tumbled 2032.31% in 2023 and soared 500.49% in 2024, its largest moves.
• Year by year, Times Interest Earned stood at $21.66 in 2022, then tumbled by 2032.31% to -$418.45 in 2023, then jumped by 103.73% to $15.6 in 2024, then plunged by 65.58% to $5.37 in 2025, then sank by 65.21% to $1.87 in 2026.
• Per Business Quant, the three latest AMPH Times Interest Earned figures stand at $1.87 (Q1 2026), $5.37 (Q4 2025), and $0.76 (Q3 2025).